Chatenay-Rivauday C - Search Results

1

Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials.

Fritsch C, Huang A, Chatenay-Rivauday C, Schnell C, Reddy A, Liu M, Kauffmann A, Guthy D, Erdmann D, De Pover A, Furet P, Gao H, Ferretti S, Wang Y, Trappe J, Brachmann SM, Maira SM, Wilson C, Boehm M, Garcia-Echeverria C, Chene P, Wiesmann M, Cozens R, Lehar J, Schlegel R, Caravatti G, Hofmann F, Sellers WR. Fritsch C, et al. Among authors: chatenay rivauday c. Mol Cancer Ther. 2014 May;13(5):1117-29. doi: 10.1158/1535-7163.MCT-13-0865. Epub 2014 Mar 7. Mol Cancer Ther. 2014. PMID: 24608574

2

Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growth.

Harbinski F, Craig VJ, Sanghavi S, Jeffery D, Liu L, Sheppard KA, Wagner S, Stamm C, Buness A, Chatenay-Rivauday C, Yao Y, He F, Lu CX, Guagnano V, Metz T, Finan PM, Hofmann F, Sellers WR, Porter JA, Myer VE, Graus-Porta D, Wilson CJ, Buckler A, Tiedt R. Harbinski F, et al. Among authors: chatenay rivauday c. Cancer Discov. 2012 Oct;2(10):948-59. doi: 10.1158/2159-8290.CD-12-0237. Epub 2012 Aug 8. Cancer Discov. 2012. PMID: 22874768

3

Caveolae: biochemical analysis.

Chatenay-Rivauday C, Cakar ZP, Jenö P, Kuzmenko ES, Fiedler K. Chatenay-Rivauday C, et al. Mol Biol Rep. 2004 Jun;31(2):67-84. doi: 10.1023/b:mole.0000031352.51910.e9. Mol Biol Rep. 2004. PMID: 15293782

4

Involvement of alpha5beta1 integrins in interleukin 8 production induced by oral viridans streptococcal protein I/IIf in cultured endothelial cells.

Al-Okla S, Chatenay-Rivauday C, Klein JP, Wachsmann D. Al-Okla S, et al. Among authors: chatenay rivauday c. Cell Microbiol. 1999 Sep;1(2):157-68. doi: 10.1046/j.1462-5822.1999.00016.x. Cell Microbiol. 1999. PMID: 11207549

5

TNF-alpha release by monocytic THP-1 cells through cross-linking of the extended V-region of the oral streptococcal protein I/II.

Chatenay-Rivauday C, Yamodo I, Sciotti MA, Troffer-Charlier N, Klein JP, Ogier JA. Chatenay-Rivauday C, et al. J Leukoc Biol. 2000 Jan;67(1):81-9. doi: 10.1002/jlb.67.1.81. J Leukoc Biol. 2000. PMID: 10648001

6

The A and the extended V N-terminal regions of streptococcal protein I/IIf mediate the production of tumour necrosis factor alpha in the monocyte cell line THP-1.

Chatenay-Rivauday C, Yamodo I, Sciotti MA, Ogier JA, Klein JP. Chatenay-Rivauday C, et al. Mol Microbiol. 1998 Jul;29(1):39-48. doi: 10.1046/j.1365-2958.1998.00881.x. Mol Microbiol. 1998. PMID: 9701801 Free article.

7

The N-terminal half part of the oral streptococcal antigen I/IIf contains two distinct functional domains.

Sciotti MA, Chatenay-Rivauday C, Yamodo I, Ogier J. Sciotti MA, et al. Among authors: chatenay rivauday c. Adv Exp Med Biol. 1997;418:699-701. doi: 10.1007/978-1-4899-1825-3_163. Adv Exp Med Biol. 1997. PMID: 9331747 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page